Similar articles for PMID: 18073583

Year	Number of Results
1947	1
1980	1
1984	1
1989	2
1997	1
1998	2
1999	1
2000	1
2002	3
2003	5
2004	4
2005	4
2006	5
2007	7
2008	6
2009	5
2010	8
2011	5
2012	3
2013	3
2014	6
2015	7
2016	6
2017	11
2018	4
2019	3
2020	6
2021	12
2022	7
2023	2
2024	0

1

Pharmacogenomic testing to prevent aminoglycoside-induced hearing loss in cystic fibrosis patients: potential impact on clinical, patient, and economic outcomes.

Veenstra DL, Harris J, Gibson RL, Rosenfeld M, Burke W, Watts C. Veenstra DL, et al. Genet Med. 2007 Oct;9(10):695-704. doi: 10.1097/gim.0b013e318156dd07. Genet Med. 2007. PMID: 18073583 Free article.

2

Cost-effectiveness of implementing routine hearing screening using a tablet audiometer for pediatric cystic fibrosis patients receiving high-dose IV aminoglycosides.

Huang SP, McKinzie CJ, Tak CR. Huang SP, et al. J Manag Care Spec Pharm. 2021 Feb;27(2):157-165. doi: 10.18553/jmcp.2021.27.2.157. J Manag Care Spec Pharm. 2021. PMID: 33506732 Free PMC article.

3

Normal hearing in a child with the m.1555A>G mutation despite repeated exposure to aminoglycosides. Has the penetrance of this pharmacogenetic interaction been overestimated?

Al-Malky G, Suri R, Sirimanna T, Dawson SJ. Al-Malky G, et al. Int J Pediatr Otorhinolaryngol. 2014 Jun;78(6):969-73. doi: 10.1016/j.ijporl.2014.02.015. Epub 2014 Feb 21. Int J Pediatr Otorhinolaryngol. 2014. PMID: 24703164

4

[Familial susceptibility to aminoglycoside ototoxicity due to the A1555G mutation in the mitochondrial DNA].

Gallo-Terán J, Morales-Angulo C, del Castillo I, Moreno-Pelayo MA, Mazón A, Moreno F. Gallo-Terán J, et al. Med Clin (Barc). 2003 Jul 12;121(6):216-8. doi: 10.1016/s0025-7753(03)73909-8. Med Clin (Barc). 2003. PMID: 12882732 Spanish.

5

Prevalence of hearing and vestibular loss in cystic fibrosis patients exposed to aminoglycosides.

Handelsman JA, Nasr SZ, Pitts C, King WM. Handelsman JA, et al. Pediatr Pulmonol. 2017 Sep;52(9):1157-1162. doi: 10.1002/ppul.23763. Epub 2017 Jul 24. Pediatr Pulmonol. 2017. PMID: 28737283 Free article.

6

Pharmacogenetics of drug-induced ototoxicity caused by aminoglycosides and cisplatin.

Lanvers-Kaminsky C, Ciarimboli G. Lanvers-Kaminsky C, et al. Pharmacogenomics. 2017 Dec;18(18):1683-1695. doi: 10.2217/pgs-2017-0125. Epub 2017 Nov 27. Pharmacogenomics. 2017. PMID: 29173064 Review.

7

Aminoglycoside ototoxicity in cystic fibrosis. Evaluation by high-frequency audiometry.

McRorie TI, Bosso J, Randolph L. McRorie TI, et al. Am J Dis Child. 1989 Nov;143(11):1328-32. doi: 10.1001/archpedi.1989.02150230086028. Am J Dis Child. 1989. PMID: 2816859

8

[Prevalence of the A1555G mutation in the mitochondrial DNA in patients with cochlear or vestibular damage due to aminoglycoside-induced ototoxicity].

Gallo-Terán J, Arellano B, Morales-Angulo C, Modamio-Høybjør S, Moreno-Pelayo MA, Ramírez-Camacho R, del Castillo I, Moreno F. Gallo-Terán J, et al. Acta Otorrinolaringol Esp. 2004 May;55(5):212-7. doi: 10.1016/s0001-6519(04)78511-8. Acta Otorrinolaringol Esp. 2004. PMID: 15461317 Free article. Spanish.

9

Extended-interval aminoglycoside administration for children: a meta-analysis.

Contopoulos-Ioannidis DG, Giotis ND, Baliatsa DV, Ioannidis JP. Contopoulos-Ioannidis DG, et al. Pediatrics. 2004 Jul;114(1):e111-8. doi: 10.1542/peds.114.1.e111. Pediatrics. 2004. PMID: 15231982

10

High frequency hearing thresholds and product distortion otoacoustic emissions in cystic fibrosis patients.

Geyer LB, Menna Barreto SS, Weigert LL, Teixeira AR. Geyer LB, et al. Braz J Otorhinolaryngol. 2015 Nov-Dec;81(6):589-97. doi: 10.1016/j.bjorl.2015.08.011. Epub 2015 Sep 8. Braz J Otorhinolaryngol. 2015. PMID: 26480907 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

113 results

Results by year